Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Colorectal Cancer Undergoing Chemotherapy

ClinicalTrials.gov ID: NCT06937177

Public ClinicalTrials.gov record NCT06937177. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 18, 2026, 5:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID: NCT06937177
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Endevica Bio; Industry
Enrollment: 120 participants

Conditions and interventions

Conditions

Cancer Weight Loss

Interventions

Placebo Drug
TCMCB07 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 27, 2025
Primary completion: Feb 28, 2027
Completion: May 31, 2027
Last update posted: May 10, 2026

2025 – 2027

United States locations

U.S. sites: 25
U.S. states: 15
U.S. cities: 24

Facility	City	State	ZIP	Site status
Investigative Site	Tucson	Arizona	85715	Recruiting
Investigative Site	Los Angeles	California	90048	Recruiting
Investigative Site	Los Angeles	California	90095	Recruiting
Investigative site	Coral Springs	Florida	33071	Recruiting
Investigative Site	Hialeah	Florida	33013	Recruiting
Investigative Site	Margate	Florida	33063	Recruiting
Investigative Site	Miami Beach	Florida	33140	Recruiting
Investigative Site	Tamarac	Florida	33321	Recruiting
Investigative Site	Atlanta	Georgia	30318	Recruiting
Investigative Site	Chicago	Illinois	60611	Not yet recruiting
Investigative Site	Hinsdale	Illinois	60521	Not yet recruiting
Investigative Site	Skokie	Illinois	60077	Not yet recruiting
Investigative Site	Wichita	Kansas	67214	Recruiting
Investigative Site	Detroit	Michigan	48201	Recruiting
Investigative Site	Lincoln	Nebraska	68506	Recruiting
Investigative Site	Omaha	Nebraska	68130	Recruiting
Investigative Site	New York	New York	10016	Recruiting
Investigative Site	Durham	North Carolina	27710	Recruiting
Investigative Site	Oklahoma City	Oklahoma	73102	Recruiting
Investigative Site	Charleston	South Carolina	29425	Not yet recruiting
Investigative Site	Memphis	Tennessee	38120	Recruiting
Investigative site	Nashville	Tennessee	37232	Not yet recruiting
Investigative Site	Kingwood	Texas	77090	Recruiting
Investigative Site	Laredo	Texas	78041	Recruiting
Investigative Site	Charlottesville	Virginia	22908	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06937177, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 10, 2026 · Synced May 18, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06937177 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →